Table 2. Time-To-Diagnosis univariate and multivariate analyses.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| HR [95%CI] | p value | AHR [95%CI] | p value | |
| AGE | ||||
| [19-55] | 1 (reference) | <0.001 | ||
| [56-65] | 0.94 [0.77-1.15] | |||
| [66-74] | 0.66 [0.54-0.81] | |||
| [75-92] | 0.78 [0.63-0.96] | |||
| GENDER | ||||
| Female | 1 (reference) | <0.001 | ||
| Male | 0.47 [0.41-0.54] | |||
| TUMOUR SITE | ||||
| Breast | 1 (reference) | <0.001 | 1 (reference) | <0.001 |
| Prostate | 0.26 [0.22-0.32] | 0.27 [0.22-0.34] | ||
| Lung | 0.78 [0.65-0.94] | 0.77 [0.64-0.93] | ||
| Sarcoma | 0.46 [0.32-0.65] | 0.46 [0.33-0.66] | ||
| Colorectal | 0.67 [0.55-0.82] | 0.67 [0.55-0.82] | ||
| ECOG PS | ||||
| 0 | 1.2 (1.04-1.39) | 0.011 | ||
| 1 | 1 (reference) | |||
| 2 | 1.47 (1.13-1.91) | |||
| >2 | 1.44 (0.92-2.25) | |||
| QUINTILE EDI | ||||
| 1 | 0.92 [0.75-1.14] | 0.02 | 0.96 [0.78-1.19] | 0.429 |
| 2 | 0.79 [0.65-0.96] | 0.88 [0.74-1.06] | ||
| 3 | 0.79 [0.65-0.96] | 0.86 [0.71-1.04] | ||
| 4 | 1.01 [0.84-1.22] | 0.99 [0.83-1.20] | ||
| 5 | 1 (reference) | 1 (reference) | ||
| T staging | ||||
| 1 | 1 (reference) | 0.001 | ||
| 2 | 0.83 [0.71-0.97] | |||
| 3 | 0.71 [0.59-0.86] | |||
| 4 | 0.72 [0.55-0.93] | |||
| N staging | ||||
| 0 | 1 (reference) | 0.037 | ||
| 1 | 1.23 [1.04-1.44] | |||
| 2 | 1.27 [1.02-1.58] | |||
| 3 | 1.03 [0.7-1.52] | |||
| M status | ||||
| 0 | 1 (reference) | 0.741 | ||
| 1 | 1.03 [0.87-1.21] | |||